These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 34182845)

  • 1. Genetically engineered exosomes display RVG peptide and selectively enrich a neprilysin variant: a potential formulation for the treatment of Alzheimer's disease.
    Yu Y; Li W; Mao L; Peng W; Long D; Li D; Zhou R; Dang X
    J Drug Target; 2021 Dec; 29(10):1128-1138. PubMed ID: 34182845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrasound-mediated augmented exosome release from astrocytes alleviates amyloid-β-induced neurotoxicity.
    Deng Z; Wang J; Xiao Y; Li F; Niu L; Liu X; Meng L; Zheng H
    Theranostics; 2021; 11(9):4351-4362. PubMed ID: 33754065
    [No Abstract]   [Full Text] [Related]  

  • 3. Human adipose tissue-derived mesenchymal stem cells secrete functional neprilysin-bound exosomes.
    Katsuda T; Tsuchiya R; Kosaka N; Yoshioka Y; Takagaki K; Oki K; Takeshita F; Sakai Y; Kuroda M; Ochiya T
    Sci Rep; 2013; 3():1197. PubMed ID: 23378928
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhanced neprilysin-mediated degradation of hippocampal Aβ42 with a somatostatin peptide that enters the brain.
    Rofo F; Ugur Yilmaz C; Metzendorf N; Gustavsson T; Beretta C; Erlandsson A; Sehlin D; Syvänen S; Nilsson P; Hultqvist G
    Theranostics; 2021; 11(2):789-804. PubMed ID: 33391505
    [No Abstract]   [Full Text] [Related]  

  • 5. The exosome of adipose-derived stem cells reduces β-amyloid pathology and apoptosis of neuronal cells derived from the transgenic mouse model of Alzheimer's disease.
    Lee M; Ban JJ; Yang S; Im W; Kim M
    Brain Res; 2018 Jul; 1691():87-93. PubMed ID: 29625119
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time-dependent effect of oligomeric amyloid-β (1-42)-induced hippocampal neurodegeneration in rat model of Alzheimer's disease.
    Karthick C; Nithiyanandan S; Essa MM; Guillemin GJ; Jayachandran SK; Anusuyadevi M
    Neurol Res; 2019 Feb; 41(2):139-150. PubMed ID: 30453864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Design, stability and efficacy of a new targeting peptide for nanoparticulate drug delivery to SH-SY5Y neuroblastoma cells.
    Huey R; Rathbone D; McCarron P; Hawthorne S
    J Drug Target; 2019 Nov; 27(9):959-970. PubMed ID: 30623678
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PTI-125 Reduces Biomarkers of Alzheimer's Disease in Patients.
    Wang HY; Pei Z; Lee KC; Lopez-Brignoni E; Nikolov B; Crowley CA; Marsman MR; Barbier R; Friedmann N; Burns LH
    J Prev Alzheimers Dis; 2020; 7(4):256-264. PubMed ID: 32920628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Temporal changes of CD68 and α7 nicotinic acetylcholine receptor expression in microglia in Alzheimer's disease-like mouse models.
    Matsumura A; Suzuki S; Iwahara N; Hisahara S; Kawamata J; Suzuki H; Yamauchi A; Takata K; Kitamura Y; Shimohama S
    J Alzheimers Dis; 2015; 44(2):409-23. PubMed ID: 25352454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulfur Nanoparticles with Novel Morphologies Coupled with Brain-Targeting Peptides RVG as a New Type of Inhibitor Against Metal-Induced Aβ Aggregation.
    Sun J; Xie W; Zhu X; Xu M; Liu J
    ACS Chem Neurosci; 2018 Apr; 9(4):749-761. PubMed ID: 29192759
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Accumulation of β-Amyloid Leads to a Decrease in Lynx1 and Lypd6B Expression in the Hippocampus and Increased Expression of Proinflammatory Cytokines in the Hippocampus and Blood Serum.
    Bychkov ML; Kirichenko AV; Paramonov AS; Kirpichnikov MP; Lukmanova EN
    Dokl Biochem Biophys; 2023 Aug; 511(1):145-150. PubMed ID: 37833597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of alpha7 nicotinic receptors enhances beta-amyloid oligomer accumulation, exacerbating early-stage cognitive decline and septohippocampal pathology in a mouse model of Alzheimer's disease.
    Hernandez CM; Kayed R; Zheng H; Sweatt JD; Dineley KT
    J Neurosci; 2010 Feb; 30(7):2442-53. PubMed ID: 20164328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Understanding molecular mechanisms of proteolysis in Alzheimer's disease: progress toward therapeutic interventions.
    Higuchi M; Iwata N; Saido TC
    Biochim Biophys Acta; 2005 Aug; 1751(1):60-7. PubMed ID: 16054018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeted exosome-mediated delivery of opioid receptor Mu siRNA for the treatment of morphine relapse.
    Liu Y; Li D; Liu Z; Zhou Y; Chu D; Li X; Jiang X; Hou D; Chen X; Chen Y; Yang Z; Jin L; Jiang W; Tian C; Zhou G; Zen K; Zhang J; Zhang Y; Li J; Zhang CY
    Sci Rep; 2015 Dec; 5():17543. PubMed ID: 26633001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-amyloid activates the mitogen-activated protein kinase cascade via hippocampal alpha7 nicotinic acetylcholine receptors: In vitro and in vivo mechanisms related to Alzheimer's disease.
    Dineley KT; Westerman M; Bui D; Bell K; Ashe KH; Sweatt JD
    J Neurosci; 2001 Jun; 21(12):4125-33. PubMed ID: 11404397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nicotinic Cholinergic Mechanisms in Alzheimer's Disease.
    Shen J; Wu J
    Int Rev Neurobiol; 2015; 124():275-92. PubMed ID: 26472533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alpha 7 nicotinic acetylcholine receptor and its effects on Alzheimer's disease.
    Ma KG; Qian YH
    Neuropeptides; 2019 Feb; 73():96-106. PubMed ID: 30579679
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutral Sphingomyelinase-2 Deficiency Ameliorates Alzheimer's Disease Pathology and Improves Cognition in the 5XFAD Mouse.
    Dinkins MB; Enasko J; Hernandez C; Wang G; Kong J; Helwa I; Liu Y; Terry AV; Bieberich E
    J Neurosci; 2016 Aug; 36(33):8653-67. PubMed ID: 27535912
    [TBL] [Abstract][Full Text] [Related]  

  • 19. N-Stearoylethanolamine protects the brain and improves memory of mice treated with lipopolysaccharide or immunized with the extracellular domain of α7 nicotinic acetylcholine receptor.
    Lykhmus O; Uspenska K; Koval L; Lytovchenko D; Voytenko L; Horid'ko T; Kosiakova H; Gula N; Komisarenko S; Skok M
    Int Immunopharmacol; 2017 Nov; 52():290-296. PubMed ID: 28963942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recombinant soluble neprilysin reduces amyloid-beta accumulation and improves memory impairment in Alzheimer's disease mice.
    Park MH; Lee JK; Choi S; Ahn J; Jin HK; Park JS; Bae JS
    Brain Res; 2013 Sep; 1529():113-24. PubMed ID: 23831521
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.